1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Snoring Global Clinical Trials Review, H2, 2014

Snoring Global Clinical Trials Review, H2, 2014

  • December 2014
  • -
  • Global Data
  • -
  • 55 pages

Snoring Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Snoring Global Clinical Trials Review, H2, 2014" provides data on the Snoring clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Snoring. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Snoring. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Snoring Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Snoring 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Snoring to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Snoring to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Snoring 24
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Merz Pharma GmbH and Co. KgaA 30
Clinical Trial Overview of Merz Pharma GmbH and Co. KgaA 30
Clinical Trial Overview of Top Institutes / Government 31
Chulalongkorn University 31
Clinical Trial Overview of Chulalongkorn University 31
Department of Health, South Africa 32
Clinical Trial Overview of Department of Health, South Africa 32
Liaoyang Central Hospital 33
Clinical Trial Overview of Liaoyang Central Hospital 33
Guilan University of Medical Sciences 34
Clinical Trial Overview of Guilan University of Medical Sciences 34
Taichung Veterans General Hospital 35
Clinical Trial Overview of Taichung Veterans General Hospital 35
Konkuk University Medical Center 36
Clinical Trial Overview of Konkuk University Medical Center 36
Helsinki University Central Hospital 37
Clinical Trial Overview of Helsinki University Central Hospital 37
University of Vermont 38
Clinical Trial Overview of University of Vermont 38
University Hospital Antwerp 39
Clinical Trial Overview of University Hospital Antwerp 39
University of Athens 40
Clinical Trial Overview of University of Athens 40
Five Key Clinical Profiles 41
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 55

List of Tables
Snoring Therapeutics, Global, Clinical Trials by Region, 2014* 6
Snoring Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Snoring Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Snoring Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Snoring Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Snoring Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Snoring Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Snoring Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Snoring to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Snoring Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Snoring Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Snoring to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Snoring Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Snoring Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Snoring Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Snoring Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Snoring Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Snoring Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Snoring Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Snoring Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Snoring Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Snoring Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Snoring Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Snoring Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH and Co. KgaA, 2014* 30
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Chulalongkorn University, 2014* 31
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 32
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Liaoyang Central Hospital, 2014* 33
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Guilan University of Medical Sciences, 2014* 34
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Taichung Veterans General Hospital, 2014* 35
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Konkuk University Medical Center, 2014* 36
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014* 37
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Vermont, 2014* 38
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Antwerp, 2014* 39
Snoring Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2014* 40

List of Figures
Snoring Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Snoring Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Snoring Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Snoring Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Snoring Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Snoring to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Snoring Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Snoring Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Snoring to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Snoring Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Snoring Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Snoring Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Snoring Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Snoring Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Snoring Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Snoring Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
GlobalData Methodology 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.